GABARAPL1 and gastric cancer: Quercetin-induced autophagy decreased its therapeutic effect in gastric cancer cells. miR-143 targeting GABARAPL1 effectively inhibited autophagy in gastric cancer cell lines, which could improve the efficacy of quercetin.